Cargando…
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273897/ https://www.ncbi.nlm.nih.gov/pubmed/34262314 http://dx.doi.org/10.2147/DMSO.S319068 |
Ejemplares similares
-
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan
por: Hisanaga, Kaori, et al.
Publicado: (2021) -
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the
era of immune checkpoint inhibitors in melanoma
Publicado: (2019) -
Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment [Corrigendum]
Publicado: (2022) -
Corrigendum to ‘Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.’ [EClinicalMedicine 59 (2023) 101981]
por: Sun, Yuming, et al.
Publicado: (2023) -
Humanistic and economic burden of fibromyalgia in Japan [Corrigendum]
Publicado: (2016)